The Daisy leadership team—Jeremy, Edward, and Ilia (remotely)—addressed the community to clarify recent confusion regarding the project’s account balances, provide a detailed blockchain audit walkthrough, and directly counter accusations of wrongdoing.
The team confirmed that, due to a misprint, an earlier broker letter understated the true account balance, which is $1.65 billion USD, and presented updated documentation and live trading account demonstrations.
They provided a comprehensive explanation of fund flows, the structure of smart contracts, and validated that all funds intended for trading were used appropriately, with transparent accounting and supporting documentation.
Leadership addressed the ongoing withdrawal delays, attributing them to sanctions and legal complexities, and reaffirmed their commitment to transparency, regulatory compliance, and eventual community “redemption.”
Action Items
As soon as possible – Leadership Team: Record and release an additional update video (including Ilia) to address new community questions.
As soon as possible – Leadership Team: Continue daily communication with the broker and provide updates to the community as allowed.
As soon as possible – Dr. Anna: Prepare and release a community video clarifying Endotech’s involvement in the Forex trading.
As soon as possible – Leadership Team: Initiate community KYC process and distribute Endotech equity as committed.
Upon sanction resolution – Leadership Team: Disclose the broker name and provide direct confirmation of account balances.
Account Balance Updates & Correction
A previous communication error understated the true trading account balance due to a misprinted broker letter; the correct balance is $1.65 billion USD.
The team presented a revised broker letter and performed a live screen share of the MT5 app to display actual sub-account balances for further transparency.
The video and documents showcasing these updates will be distributed to ensure all community members receive accurate information.
Response to Accusations & Community Concerns
Leadership categorically denied any accusations of fund misappropriation, fraud, or the use of advanced mechanisms to move or hide community funds.
Comprehensive, step-by-step blockchain analysis was presented to show all fund flows from member contributions through to trading, bonus pools, and withdrawals.
It was emphasized that Daisy has always been a crowdfunding project for Endotech AI development, not an investment or hedge fund, and that all messaging has consistently reflected this.
Blockchain & Financial Ecosystem Transparency
Detailed walkthrough provided of the Daisy ecosystem, including smart contracts, fund allocation for trading (crypto/Forex), reserve management, withdrawals, and bonus structures.
Leadership demonstrated how all trading funds were tracked and could be independently verified on the blockchain, including wallet addresses and transaction hashes.
The team clarified misunderstandings regarding wallet ownership and fund flows into centralized exchanges, noting that transfers to Binance and similar platforms were for legitimate trading activities, not fund diversion.
The audit process was limited by sanctions—external auditors cannot currently access certain accounts—but historic crypto-side audits were performed, and the team is committed to future third-party audits when possible.
Explanation of Fund Management & Delays
The process for managing reserves and broker deposits was explained in detail, showing regular, transparent deposits to the broker and proportional growth in trading balances.
The current withdrawal delays are attributed to regulatory sanctions and banking restrictions connected to the Russia-Ukraine conflict, not internal wrongdoing.
Key documents from supporting banks and brokers were shared to demonstrate that the team expected, and had reason to expect, a resolution and access to funds as recently as June 2024.
The team continues to work daily with the broker and legal advisors, seeking release of funds and updating the community as information permits.
Forward Plans, Regulatory Steps, and Equity Distribution
The team reiterated that Daisy began as a crowdfunding project, with legal commitments to both the R&D of Endotech AI and distribution of Endotech equity (22% total) to the community.
Efforts are underway to secure asset management licenses, launch KYC processes, and position for a future where regulatory compliance and transparency are further heightened.
Plans to launch a new fund model in the future were announced, leveraging the lessons learned, and promising improved safeguards and profitability for participants.
Decisions
Publish updated broker letter and video demonstration — To immediately correct the balance reporting error and provide transparent proof of current account status.
Hold further updates until Ilia can participate — To ensure full leadership representation and address additional community questions raised.
Open Questions / Follow-Ups
When will sanctions be resolved to allow broker withdrawals and full disclosure (including broker name)?
What is the timeline for launching the KYC process and distributing Endotech equity to the community?
Will there be opportunities for an independent third-party audit of trading accounts once legal restrictions are lifted?
What contingency plans are in place if broker withdrawals remain blocked for an extended period?
When will Dr. Anna’s community video be released to further address trading and AI development questions?